Explorer les evidences

6,5 %Among offspring of non-diabetic parents in Cameroon, 6.5% were glucose intolerant, all with impaired glucose tolerance.

Camerounglucose intolerancepublié 2000Diabetes careeurope_pmcdocument de 2 observationsDOI 10.2337/diacare.23.12.1761

10,1 %The intervention induced a reduction in HbA1c from 10.1% to 6.7%.

Cameroundiabète de type 2publié 2019Diabetes research and clinical practiceeurope_pmcdocument de 4 observations

3 specimensPhylogenetic analysis of the gp41 region of 123 HIV-1-seropositive specimens from Cameroon showed that 3 were group O.

CamerounVIH/sidapublié 2000AIDS Research and Human RetrovirusesOpenAlexdocument de 7 observations

5 %Le paludisme est responsable de 5 % des décès chez les femmes enceintes au Cameroun selon les rapports d’activités du PNLP en 2006.

Camerounpaludismeobservé 2006HAL · Unilimdocument de 98 observations

8 patientsAmong 24 genetically tested Cameroonian patients with congenital adrenal hyperplasia, CYP21A2 mutation was found in 8 patients.

Camerouncongenital adrenal hyperplasiapublié 2022Journal of pediatric endocrinology & metabolism : JPEMeurope_pmcdocument de 6 observations

5 %The prevalence of the 77I substitution in protease sequences was 5% (3/57) among 57 HIV-1-infected treatment-naive individuals from Cameroon.

CamerounVIH/sidapublié 2011AIDS Research and Human RetrovirusesOpenAlexdocument de 24 observations

1,9 %The vertical transmission rate was 1.9% (6/321) among infants born to mothers who commenced HAART during pregnancy.

CamerounVIH/sidaobservé November 2007 to October 2010publié 2019Paediatrics and international child healthPubMeddocument de 7 observations

3 %Old World monkeys showed infrequent seroreactivity (3%) to HBoV.

CamerounHBoVpublié 2010Journal of VirologyOpenAlexdocument de 10 observations

30 %Prevalence of obesity was more than 30% in girls in Nauru, the Cook Islands, and Palau in 2016.

Camerounobésitéobservé 2016publié 2017Lancet (London, England)europe_pmcdocument de 12 observations

5 %Coronary heart disease may affect 5% to 8% of type 2 diabetic patients in sub-Saharan Africa.

Camerouncoronary heart disease · diabète de type 2publié 2005Circulationeurope_pmcdocument de 5 observationsDOI 10.1161/circulationaha.105.544312

12,5 %Among 128 patients routinely receiving highly active antiretroviral therapy in an HIV/AIDS outpatient clinic in Cameroon, 12.5% had resistance to nucleoside reverse transcriptase inhibitors (NRTIs).

CamerounVIH/sidapublié 2006Emerging infectious diseasesOpenAlexdocument de 4 observationsDOI 10.3201/eid1206.050860

16 days_per_patient_per_yearPatients in Eurasia experienced an annual number of diabetes-related inpatient days of 16.0 days per patient (mean±SD: 16.0±30.0).

Cameroundiabète de type 2observé 2011-2012publié 2017BMJ open diabetes research & careeurope_pmc

4 %In Cameroon, 4 out of 90 participants had severe eGFR impairment (<30 mL/min), representing 4%.

Camerounmaladie rénale chroniqueHAL · Unilimdocument de 205 observations

11,7 mm HgSystolic blood pressure dropped by 11.7 mm Hg between baseline and final visits.

Camerounhypertension artériellepublié 2009Journal of clinical hypertension (Greenwich, Conn.)europe_pmcdocument de 5 observationsDOI 10.1111/j.1751-7176.2009.00165.x

1 505 900 000 casesThe most prevalent neurological disorder in 2015 was tension-type headache, with 1505.9 million cases.

Camerountension-type headacheobservé 2015publié 2017The Lancet. Neurologyeurope_pmcdocument de 10 observations

50,7 %The prevalence of undiagnosed diabetes in the Africa Region (AFR) was 50.7%.

Camerounundiagnosed diabetespublié 2014Diabetes research and clinical practiceeurope_pmcdocument de 14 observations

75 %Le PSNLP 2014-2018 visait à réduire de 75 % la mortalité et la morbidité dues au paludisme par rapport à la situation de 2000 d’ici 2018.

Camerounpaludismeobservé 2018HAL · Unilimdocument de 98 observations

89 %Among 36 HIV-1 infected blood donors in Cameroon, 32 (89%) responded to at least one peptide pool in the IFNγ ELISPOT assay.

CamerounVIH/sidapublié 2009RetrovirologyOpenAlexdocument de 6 observationsDOI 10.1186/1742-4690-6-s3-p273

21 patientsA cohort of patients of sub-Saharan African origin included 21 patients with type 1 diabetes.

Cameroundiabète de type 1publié 2004Diabeteseurope_pmcdocument de 8 observationsDOI 10.2337/diabetes.53.3.645

56,6 %Hypertension prevalence among Bamileke in Cameroon was 56.6% [95% CI 49.4–63.8].

Camerounhypertension artériellepublié 2019Journal of hypertensioneurope_pmcdocument de 20 observationsDOI 10.1097/hjh.0000000000002165

4,3 %Pretreatment HIV drug resistance (PDR) prevalence among ART initiators in rural areas of Cameroon was 4.3% (95% CI 1.2%–14.3%).

CamerounVIH/sidaobservé 2015publié 2018Journal of Antimicrobial ChemotherapyOpenAlexdocument de 12 observationsDOI 10.1093/jac/dky221

2,6 odds_ratioThe summary odds ratio between non-autoimmune diabetes and Parvovirus B19 infection risk was 2.6 (95% CI: 0.7–9.1) based on one study.

Camerounnon-autoimmune diabetes mellitus · parvovirus B19publié 2021Scientific reportseurope_pmcdocument de 11 observationsDOI 10.1038/s41598-021-88598-6

56 patientsA total of 56 diabetic patients with serious hand or foot infections were included in the final analyses.

Cameroundiabète (non précisé) · hand or foot infectionsobservé 2006–2008publié 2010The Journal of foot and ankle surgery : official publication of the American College of Foeurope_pmcdocument de 12 observations

24 %161 (24%) of samples yielded a detectable viral load (>400 copies/mL).

CamerounVIH/sidapublié 2012Journal of the International AIDS Societyeurope_pmcdocument de 39 observations

1 500 000 casesIn 2017, there were 1.5 million incident cases of tracheal, bronchus, and lung cancer in men.

Camerountracheal, bronchus, and lung cancerobservé 2017publié 2019JAMA oncologyeurope_pmcdocument de 25 observationsDOI 10.1001/jamaoncol.2019.2996